Publications

Detailed Information

Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction

DC Field Value Language
dc.contributor.authorLee, Jung Ryeol-
dc.contributor.authorKim, Seok Hyun-
dc.contributor.authorKim, Sun Mie-
dc.contributor.authorJee, Byung Chul-
dc.contributor.authorSuh, Chang Suk-
dc.contributor.authorKim, Jung Gu-
dc.contributor.authorMoon, Shin Yong-
dc.contributor.authorChoi, Young Min-
dc.contributor.authorKu, Seung-Yup-
dc.date.accessioned2012-06-04T06:46:04Z-
dc.date.available2012-06-04T06:46:04Z-
dc.date.issued2010-10-
dc.identifier.citationHUMAN REPRODUCTION; Vol.25 10; 2597-2604ko_KR
dc.identifier.issn0268-1161-
dc.identifier.urihttps://hdl.handle.net/10371/76798-
dc.description.abstractAnti-Mullerian hormone (AMH) has been suggested as a marker of ovarian reserve and predictor of ovarian response to controlled ovarian hyperstimulation (COH). Several studies have demonstrated AMH changes during follicular and luteal phases during COH, but not after human chorionic gonadotrophin (hCG) administration. The objectives of this study were to investigate changes in AMH levels during the entire COH cycle and to clarify the regulatory mechanism of AMH secretion. In addition, we analyzed the COH outcome parameters to determine the optimal timing for AMH measurement to predict outcome. The study included 74 women who underwent in vitro fertilization (IVF) cycles with a GnRH agonist or antagonist protocol. Serum AMH and inhibin B levels were measured at baseline, Day 5 of stimulation (d5), day of hCG administration (dhCG), day of oocyte retrieval (dOPU) and 14 days after oocyte retrieval (dPO14). Follicular fluid (FF) from dominant follicles upon oocyte retrieval were also analyzed for AMH and inhibin B concentrations. AMH levels were analyzed for changes during the cycle and for correlations with COH outcome parameters. Serum AMH levels decreased progressively during COH until dhCG, then increased on dOPU and further increased on dPO14. Serum and FF AMH levels and dynamic changes were not different between the GnRH agonist and antagonist cycles. Serum AMH levels on every sample day and the FF AMH levels were significantly correlated with outcomes of COH, such as dose of gonadotrophins used, estradiol level on dhCG and number of retrieved oocytes; the strength of the relationship was highest for baseline AMH. The results of the present study suggest that changes in the hormonal milieu during stimulation and after the LH surge may affect AMH secretion. Serum AMH levels during COH are good markers to predict ovarian response, but the baseline serum level seems to be the most predictive marker.ko_KR
dc.language.isoenko_KR
dc.publisherOXFORD UNIV PRESSko_KR
dc.subjectanti-Mullerian hormoneko_KR
dc.subjectinhibin Bko_KR
dc.subjectGnRH antagonistko_KR
dc.subjectGnRH agonistko_KR
dc.subjectcontrolled ovarian hyperstimulationko_KR
dc.titleAnti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome predictionko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor이정렬-
dc.contributor.AlternativeAuthor김석현-
dc.contributor.AlternativeAuthor김선미-
dc.contributor.AlternativeAuthor지병철-
dc.contributor.AlternativeAuthor구승엽-
dc.contributor.AlternativeAuthor서창석-
dc.contributor.AlternativeAuthor최영민-
dc.contributor.AlternativeAuthor김정구-
dc.contributor.AlternativeAuthor문신용-
dc.identifier.doi10.1093/humrep/deq204-
dc.citation.journaltitleHUMAN REPRODUCTION-
dc.description.citedreferenceGnoth C, 2008, HUM REPROD, V23, P1359, DOI 10.1093/humrep/den108-
dc.description.citedreferencevan Disseldorp J, 2008, J CLIN ENDOCR METAB, V93, P2129, DOI 10.1210/jc.2007-2093-
dc.description.citedreferenceElgindy EA, 2008, FERTIL STERIL, V89, P1670, DOI 10.1016/j.fertnstert.2007.05.040-
dc.description.citedreferenceLee JR, 2008, FERTIL STERIL, V89, P860, DOI 10.1016/j.fertnstert.2007.04.010-
dc.description.citedreferenceTakahashi C, 2008, FERTIL STERIL, V89, P586, DOI 10.1016/j.fertnstert.2007.03.080-
dc.description.citedreferenceShin SY, 2008, J KOREAN MED SCI, V23, P104, DOI 10.3346/jkms.2008.23.1.104-
dc.description.citedreferenceCatteau-Jonard S, 2007, J CLIN ENDOCR METAB, V92, P4138, DOI 10.1210/jc.2007-0868-
dc.description.citedreferenceThomas FH, 2007, ENDOCRINOLOGY, V148, P2273, DOI 10.1210/en.2006-1501-
dc.description.citedreferenceFanchin R, 2007, J CLIN ENDOCR METAB, V92, P1796, DOI 10.1210/jc.2006-1053-
dc.description.citedreferenceLa Marca A, 2007, HUM REPROD, V22, P766, DOI 10.1093/humrep/del421-
dc.description.citedreferencePellatt L, 2007, J CLIN ENDOCR METAB, V92, P240, DOI 10.1210/jc.2006-1582-
dc.description.citedreferenceLa Marca A, 2006, HUM REPROD, V21, P3103, DOI 10.1093/humrep/del291-
dc.description.citedreferenceAndersen CY, 2006, J CLIN ENDOCR METAB, V91, P4064, DOI 10.1210/jc.2006-1066-
dc.description.citedreferenceNakhuda GS, 2006, FERTIL STERIL, V85, P1541, DOI 10.1016/j.fertnstert.2005.10.052-
dc.description.citedreferenceAsimakopoulos B, 2006, J ENDOCRINOL INVEST, V29, pRC5-
dc.description.citedreferenceSilberstein T, 2006, HUM REPROD, V21, P159, DOI 10.1093/humrep/dei270-
dc.description.citedreferenceLa Marca A, 2005, J SOC GYNECOL INVEST, V12, P545, DOI 10.1016/j.jsgi.2005.06.001-
dc.description.citedreferenceEldar-Geva T, 2005, HUM REPROD, V20, P1814, DOI 10.1093/humrep/deh873-
dc.description.citedreferencePenarrubia J, 2005, HUM REPROD, V20, P915, DOI 10.1093/humrep/deh718-
dc.description.citedreferenceHohmann FP, 2005, EUR J ENDOCRINOL, V152, P395, DOI 10.1530/eje.1.01871-
dc.description.citedreferenceFanchin R, 2005, HUM REPROD, V20, P747, DOI 10.1093/humrep/deh669-
dc.description.citedreferenceUrbancsek J, 2005, FERTIL STERIL, V83, P341, DOI 10.1016/j.fernstert.2004.06.065-
dc.description.citedreferenceLa Marca A, 2004, HUM REPROD, V19, P2738, DOI 10.1093/humrep/deh508-
dc.description.citedreferenceHazout A, 2004, FERTIL STERIL, V82, P1323, DOI 10.1016/j.fertnstert.2004.03.061-
dc.description.citedreferenceMuttukrishna S, 2004, BJOG-INT J OBSTET GY, V111, P1248, DOI 10.1111/j.1471-0528.2004.00452.x-
dc.description.citedreference2004, FERTIL STERIL, V81, P19-
dc.description.citedreferenceFanchin R, 2003, HUM REPROD, V18, P328, DOI 10.1093/humrep/deg043-
dc.description.citedreferenceSeifer DB, 2002, FERTIL STERIL, V77, P468-
dc.description.citedreferenceDurlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076-
dc.description.citedreferencede Vet A, 2002, FERTIL STERIL, V77, P357-
dc.description.citedreferenceVANROOIJ, 2002, HUM REPROD, V17, P3065-
dc.description.citedreferenceDurlinger ALL, 2001, ENDOCRINOLOGY, V142, P4891, DOI 10.1210/en.142.11.4891-
dc.description.citedreferenceWelt CK, 2001, J CLIN ENDOCR METAB, V86, P2531-
dc.description.citedreferenceWeiss JM, 2001, EUR J ENDOCRINOL, V144, P677-
dc.description.citedreferenceOrtmann O, 2001, HUM REPROD, V16, P608-
dc.description.citedreferenceCreus M, 2000, HUM REPROD, V15, P2341-
dc.description.citedreferenceCorson SL, 1999, HUM REPROD, V14, P2818-
dc.description.citedreferenceJosso N, 1998, MOL CELL ENDOCRINOL, V145, P3-
dc.description.citedreferenceSeifer DB, 1997, FERTIL STERIL, V67, P110-
dc.description.citedreferenceLockwood GM, 1996, CLIN ENDOCRINOL, V45, P741-
dc.description.citedreferenceBAARENDS WM, 1995, ENDOCRINOLOGY, V136, P4951-
dc.description.tc2-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share